Immunohistochemistry assessment of P53 protein in basal cell carcinoma

Iranian Journal of Allergy, Asthma and Immunology

Volumn 4, Issue 4, 2005, Pages 167-171

  Ghaderi, Reza ^a   Haghighi, Fatemeh ^b  

^a BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Basal cell carcinoma; Gene expression; Immunohistochemistry; Tumor suppressor protein p53

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER PATIENT; CANCER TISSUE; CHI SQUARE TEST; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; GENE EXPRESSION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; SKIN DISEASE; TISSUE SECTION; TUMOR LOCALIZATION;

EID: 84966553257     PISSN: 17351502     EISSN: 17355249     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Boldrini L, Loggini B, Gisfredi S, Zucconi Y, Baldinotti F, Fogli A, et al. Mutations of Fas (APO-1/CD95) and p53 genes in nonmelanoma skin cancer. J Cutan Med Surg 2003; 7(2):112-8.
2. Bertram JS. The molecular biology of cancer. Mol Aspects Med 2000; 21(6):167-223.
3. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411(6835):342-348.
4. McDonald ER, El-Deiry WS. Checkpoint genes in cancer. Ann Med 2001; 33(2):113-22.
5. Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, Xu B, et al. MAP kinases. Chem Rev 2001; 101(8):2449-76.
6. Krontiris TG. Oncogenes. N Engl J Med 1995; 333(5):303-6.
7. Sherr CJ. Principles of tumor suppression. Cell 2004; 116(2):235-46.
8. Hussain SP, Harris CC. Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res 1998; 58(18):4023-37.
9. Soussi T, Beroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 2001; 1(3):233-40.
10. Soussi T, Dehouche K, Beroud C. P53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis. Hum Mutat 2000; 15(1):105-13.
11. Malkin D. P53 and the Li-Fraumeni syndrome. Biochim Biophys Acta 1994; 1198(2-3):197-213.
12. Kim MY, Park HJ, Baek SC, Byun DG, Houh D. Mutations of the p53 and PTCH gene in basal cell carcinomas: UV mutation signature and strand bias. J Dermatol Sci 2002; 29(1):1-9.
13. Rady P, Scinicariello F, Wagner RF Jr, Tyring SK. p53 mutations in basal cell carcinomas. Cancer Res 1992; 52(13):3804-6.
14. Moles JP, Moyret C, Guillot B, Jeantar P, Bassett-Sequin N. p53 gene mutations in human epithelial skin cancer. Oncogene 1993; 8(3):583-588.
15. van der Riet P, Karp D, Farmer E, Sidransky D. Progression of basal cell carcinoma through loss of chromosome 9q and inactivation of a single p53 allele. Cancer Res 1994; 54(1):25-27.
16. Hollstein M, Sidransky D, Vogelstein B, Harris C. p53 mutations in human cancers. Science 1991; 253 (5015):49-53.
17. Hoogervorst EM, Steeg, HV. Nucleotide excision repair and p53 deficient mouse models in cancer research. Mutat Res 2005; 574(1-2):3-21.
18. Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A 1993; 90(9):4216-20.
19. Dumaz N, Drougard C, Sarasin A, Daya-Grosjean L. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc Natl Acad Sci U S A 1993; 90(22):10529-33.
20. McGregor WG, Chen RH, Lukash L, Maher VM, McCormick JJ. Cell cycle-dependent strand bias for UVinduced mutations in the transcribed strand of excision repair-proficient human fibroblasts but not in repairdeficient cells. Mol Cell Biol 1991; 11(4):1927-34.
21. Campbell C, Quinn AG, Angus B, Rees JL. The relation between p53 mutation and p53 immunostaining in nonmelanoma skin cancer. Br J Dermatol 1993; 129(3):235-41.
22. Kubo Y, Urano Y, Yoshimoto K, Iwahana H, Fukuhara K, Arase S, et al. p53 gene mutations in human skin cancers and precancerous lesions: comparison with immunohistochemical analysis. J Invest Dermatol 1994; 102(4):440-4.
23. Stratigos AJ, Kapranos N, Petrakou E, Anastasiadou A, Pagouni A, Christofidou E, et al. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation. J Eur Acad Dermatol Venereol 2005; 19(2):180-6.
24. Bodak N, Queille S, Avril MF, Bouadjar B, Drougard C, Sarasin A, et al. High levels of patched gene mutations in basal-cell carcinomas from patients with xeroderma pigmentosum. Proc Natl Acad Sci U S A 1999; 96(9):5117-22.